HaiThuy N Nguyen1, Shailendra Das2, Maria C Gazzaneo2, Ernestina Melicoff2, George B Mallory2, Karen W Eldin3, R Paul Guillerman4. 1. Department of Pediatric Radiology, Texas Children's Hospital, 6701 Fannin St., Houston, TX, 77030, USA. hnnguyen@texaschildrens.org. 2. Department of Pediatrics, Section of Pulmonary Medicine, Texas Children's Hospital, Houston, TX, USA. 3. Department of Pathology, Texas Children's Hospital, Houston, TX, USA. 4. Department of Pediatric Radiology, Texas Children's Hospital, 6701 Fannin St., Houston, TX, 77030, USA.
Abstract
BACKGROUND: Pleuroparenchymal fibroelastosis (PPFE) may be underdiagnosed clinically and radiographically in children with a remote history of cancer, leading to a delay in care and unnecessary lung biopsies. OBJECTIVE: To describe the characteristic clinical and radiologic findings of PPFE in a cohort of children to facilitate recognition and noninvasive diagnosis. MATERIALS AND METHODS: Clinical presentation, history of chemotherapy or radiation therapy, lung or bone marrow transplantation, and lung function testing and outcome were retrospectively extracted from the electronic medical records of eight children treated at our institution's pulmonary medicine clinic with histopathology confirmation of PPFE from 2008 to 2018. Two pediatric radiologists evaluated the chest imaging studies for the presence or absence of published radiologic findings of PPFE in adults, including platythorax, pneumothorax, upper lobe predominant pleural and septal thickening, and bronchiectasis. Platythorax indices were calculated from the normal chest CT exams of eight age- and gender-matched individuals obtained via the radiology search engine. RESULTS: The mean presentation age was 12.9 years (range: 7-16 years). Seven of the eight had a history of chemotherapy and radiation therapy for cancer. Three of the eight had undergone bone marrow transplantation and none had undergone lung transplantation. The mean time between chemotherapy, radiation therapy, and/or bone marrow transplantation and the presentation of PPFE was 8.4 years (range: 5.6-12.1 years). Most of the patients presented with dyspnea (63%), cough (50%) and/or pneumothorax (38%). The mean percentage of predicted FEV1 (forced expiratory volume in one second) was 14.1 (range: 7.7-27.5). All eight patients demonstrated platythorax, bronchiectasis, pleural and septal thickening (upper lobes in four, upper and lower lobes in four) and six had pneumothorax. Five underwent lung biopsies, four of whom developed pneumothoraces. CONCLUSION: Clinical and radiologic findings of pediatric PPFE are similar to those in adults, although a majority of the former have a history of treated cancer. Clinical presentation of restrictive lung disease, dyspnea, cough or spontaneous pneumothorax years after treatment for childhood cancer combined with platythorax, upper lobe pleural and septal thickening and traction bronchiectasis on chest CT establishes a presumptive diagnosis of PPFE.
BACKGROUND:Pleuroparenchymal fibroelastosis (PPFE) may be underdiagnosed clinically and radiographically in children with a remote history of cancer, leading to a delay in care and unnecessary lung biopsies. OBJECTIVE: To describe the characteristic clinical and radiologic findings of PPFE in a cohort of children to facilitate recognition and noninvasive diagnosis. MATERIALS AND METHODS: Clinical presentation, history of chemotherapy or radiation therapy, lung or bone marrow transplantation, and lung function testing and outcome were retrospectively extracted from the electronic medical records of eight children treated at our institution's pulmonary medicine clinic with histopathology confirmation of PPFE from 2008 to 2018. Two pediatric radiologists evaluated the chest imaging studies for the presence or absence of published radiologic findings of PPFE in adults, including platythorax, pneumothorax, upper lobe predominant pleural and septal thickening, and bronchiectasis. Platythorax indices were calculated from the normal chest CT exams of eight age- and gender-matched individuals obtained via the radiology search engine. RESULTS: The mean presentation age was 12.9 years (range: 7-16 years). Seven of the eight had a history of chemotherapy and radiation therapy for cancer. Three of the eight had undergone bone marrow transplantation and none had undergone lung transplantation. The mean time between chemotherapy, radiation therapy, and/or bone marrow transplantation and the presentation of PPFE was 8.4 years (range: 5.6-12.1 years). Most of the patients presented with dyspnea (63%), cough (50%) and/or pneumothorax (38%). The mean percentage of predicted FEV1 (forced expiratory volume in one second) was 14.1 (range: 7.7-27.5). All eight patients demonstrated platythorax, bronchiectasis, pleural and septal thickening (upper lobes in four, upper and lower lobes in four) and six had pneumothorax. Five underwent lung biopsies, four of whom developed pneumothoraces. CONCLUSION: Clinical and radiologic findings of pediatric PPFE are similar to those in adults, although a majority of the former have a history of treated cancer. Clinical presentation of restrictive lung disease, dyspnea, cough or spontaneous pneumothorax years after treatment for childhood cancer combined with platythorax, upper lobe pleural and septal thickening and traction bronchiectasis on chest CT establishes a presumptive diagnosis of PPFE.
Authors: R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Taryn L Reddy; Masaki Tominaga; David M Hansell; Jan von der Thusen; Doris Rassl; Helen Parfrey; Suzy Guy; Orion Twentyman; Alexandra Rice; Toby M Maher; Elisabetta A Renzoni; Athol U Wells; Andrew G Nicholson Journal: Eur Respir J Date: 2012-03-22 Impact factor: 16.671
Authors: Anne Stone; Danielle Novetsky Friedman; Stefan Worgall; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Xian Wu; Nai-Kong Cheung; Charles A Sklar Journal: J Pediatr Hematol Oncol Date: 2017-10 Impact factor: 1.289
Authors: Jan H von der Thüsen; David M Hansell; Masaki Tominaga; Paul A Veys; Michael T Ashworth; Catherine M Owens; Andrew G Nicholson Journal: Mod Pathol Date: 2011-08-05 Impact factor: 7.842
Authors: Andrew C Dietz; Yan Chen; Yutaka Yasui; Kirsten K Ness; James S Hagood; Eric J Chow; Marilyn Stovall; Joseph P Neglia; Kevin C Oeffinger; Ann C Mertens; Leslie L Robison; Gregory T Armstrong; Daniel A Mulrooney Journal: Cancer Date: 2016-08-09 Impact factor: 6.860
Authors: Rajkumar Venkatramani; Sunil Kamath; Kenneth Wong; Arthur J Olch; Jemily Malvar; Richard Sposto; Fariba Goodarzian; David R Freyer; Thomas G Keens; Leo Mascarenhas Journal: Int J Radiat Oncol Biol Phys Date: 2013-05-29 Impact factor: 7.038
Authors: HaiThuy N Nguyen; Morgan P McBee; Cara E Morin; Akshay Sharma; Kalyani R Patel; Manuel Silva-Carmona; R Paul Guillerman Journal: Pediatr Radiol Date: 2022-06-14